Gartisertib

SI-7579

Gartisertib, >98% (HPLC)

CAS No. : [1613191-99-3]

Synonyms : VX-803; M-4344; ATR inhibitor 2

IUPAC Name : 2-Amino-6-fluoro-N-(5-fluoro-4-(4-(4-(oxetan-3-yl)piperazine-1-carbonyl)piperidin-1-yl)pyridin-3-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Gartisertib selectively targets ATR with picomolar affinity and potently inhibits ATR‑mediated Chk1 phosphorylation (IC₅₀ = 8 nM). Its oral activity and robust suppression of ATR signaling support its antitumor efficacy.

References : Zenke T. F. et al.: Cancer Res 79 (13), 369, 2019; Gorecki L. et al.: Pharmacol. Ther., 107518, 2020.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.